Literature DB >> 21858813

HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer.

Aifen Lin1, Xia Zhang, Hui-Hui Xu, Dan-Ping Xu, Yan-Yun Ruan, Wei-Hua Yan.   

Abstract

Aberrant HLA-G expression is associated with tumor invasiveness and poor clinical prognosis; however, there is a lack of preclinical animal model to address whether HLA-G plays a causal role in the unfavorable prognosis of malignancies. In the current study, ovarian carcinoma cell lines (HO-8910 and Ovcar-3) were transfected with HLA-G gene. HLA-G expression was analyzed with western blot and flow cytometry. Transwell experiment was performed to analyze the cell migration and invasion capability and/or multicellular spheroid formation was investigated with the 3D culture assay in vitro. The effects of HLA-G expression for tumor cell organ metastasis and for mouse survival was analyzed with the Balb/c nu/nu mouse model. Our data showed that HO-8910-G and Ovcar-3-G cells are of higher invasion potential compared with the parental HO-8910 and Ovcar-3 cells. Multicellular spheroid formation exists only in HO-8910-G cells in a 3D culture assay. In Balb/c nu/nu mouse model, widespread metastasis was observed in mice xenografted with HO-8910-G cells, but not in the group with parental cells. Mouse survival was dramatically decreased in HO-8910-G and Ovcar-3-G xenografted mice than that with HO-8910 and Ovcar-3 cells, respectively. In summary, our study provided the first evidence that HLA-G expression is associated with tumor metastasis and with poor survival in an animal model with ovarian cancer.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858813     DOI: 10.1002/ijc.26375

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Proteomic analysis of knock-down HLA-G in invasion of human trophoblast cell line JEG-3.

Authors:  Haiyan Liu; Xueyuan Liu; Hong Jin; Fengying Yang; Weirong Gu; Xiaotian Li
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

Review 2.  Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.

Authors:  Aswathy R Devan; Bhagyalakshmi Nair; Ayana R Kumar; Balachandran S Vinod; Lekshmi R Nath
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

Review 3.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.

Authors:  Danli Wu; Isere Kuiaste; Philippe Moreau; Edgardo Carosella; Patricia Yotnda
Journal:  Oncotarget       Date:  2015-11-10

Review 5.  HLA-G: A New Immune Checkpoint in Cancer?

Authors:  Daniëlle Krijgsman; Jessica Roelands; Wouter Hendrickx; Davide Bedognetti; Peter J K Kuppen
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

6.  Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients.

Authors:  Aifen Lin; Xia Zhang; Rui-Li Zhang; Jian-Gang Zhang; Wen-Jun Zhou; Wei-Hua Yan
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

7.  High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.

Authors:  Matti Ullah; Dallel Azazzen; Rachid Kaci; Nadia Benabbou; Eric Pujade Lauraine; Marc Pocard; Massoud Mirshahi
Journal:  Neoplasia       Date:  2019-02-22       Impact factor: 5.715

8.  Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.

Authors:  Hui-Hui Xu; Jun Gan; Dan-Ping Xu; Lu Li; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

9.  Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study.

Authors:  Marlies S Reimers; Charla C Engels; Hein Putter; Hans Morreau; Gerrit Jan Liefers; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  BMC Cancer       Date:  2014-07-05       Impact factor: 4.430

Review 10.  Immunomodulatory properties of HLA-G in infectious diseases.

Authors:  Laurence Amiot; Nicolas Vu; Michel Samson
Journal:  J Immunol Res       Date:  2014-04-15       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.